BME : ROVI.MC

Laboratorios Farmaceuticos Rovi, S.A. — Earnings Estimates

$57.45 EUR

$1.25 (2.22%)

Volume
175.96K
Average Volume
153.66K
Market Capitalization
$2.94B
P/E Ratio
22.35
Dividend Yield
1.67%
Price Target
Year High
$86.70
Year Low
$51.65
Day High
—
Day Low
—
Payout Ratio
$0.36
Current Ratio
$3.66

Annual earnings financials

ROVI.MC financial data with annual/quarterly toggle

ROVI.MC GAAP EPS - Annual & Quarterly

ROVI.MC Sales Revenue - Annual & Quarterly

ROVI.MC Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

ROVI.MC Estimated and Actual Revenue by Quarter
ROVI.MC Estimated and Actual EPS by Quarter
ROVI.MC Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2026-06-30 4 50.78M 54.52M 53M 45.11M 48.43M 47.08M
2026-03-31 2 46.08M 46.6M 46.34M 40.93M 41.39M 41.16M
2025-12-31 7 62.16M 63.6M 62.71M 55.21M 56.49M 55.7M
2025-09-30 3 62.78M 63.68M 63.08M 55.76M 56.56M 56.03M
2025-06-30 1 47.75M 47.75M 47.75M 42.42M 42.42M 42.42M
2025-03-31 4 44.34M 45.42M 45.13M 39.39M 40.35M 40.09M
ROVI.MC Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2026-06-30 4 - - - 20.34M 21.84M 21.23M
2026-03-31 2 - - - 18.46M 18.67M 18.57M
2025-12-31 7 - - - 24.9M 25.48M 25.12M
2025-09-30 3 - - - 25.15M 25.51M 25.27M
2025-06-30 1 - - - 19.13M 19.13M 19.13M
2025-03-31 4 - - - 17.77M 18.2M 18.08M
ROVI.MC Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2026-06-30 4 169.06M 181.52M 176.44M 0 0 0 0
2026-03-31 2 153.42M 155.15M 154.28M 0 0 0 0
2025-12-31 7 206.93M 211.73M 208.76M 0 0 0 0
2025-09-30 3 209M 212M 210M 0 0 0 0
2025-06-30 1 158.98M 158.98M 158.98M 0 0 0 0
2025-03-31 4 147.63M 151.22M 150.25M 0 0 0 0